Dr. Peter McCullough

During the pandemic, or late in the hours of the pandemic, Toxeluzumab had some utility in patients like this because a lot of this overwhelming immune response is this so-called cytokine storm. But who knows? You know what I mean? Sometimes the body just can't withstand this, particularly if you're monkeying with the immune system with very powerful medication.

During the pandemic, or late in the hours of the pandemic, Toxeluzumab had some utility in patients like this because a lot of this overwhelming immune response is this so-called cytokine storm. But who knows? You know what I mean? Sometimes the body just can't withstand this, particularly if you're monkeying with the immune system with very powerful medication.

It's true. You know, I had examined her multiple times. She was so frail and recall in a scleroderma system of sclerosis, the skin on the body gets very tight and there's a form of restrictive lung disease. She had the effects on her hands. And in that scenario, even a bacterial pneumonia, like a pneumococcal or haemophilus influenza pneumonia could be fatal as well.

It's true. You know, I had examined her multiple times. She was so frail and recall in a scleroderma system of sclerosis, the skin on the body gets very tight and there's a form of restrictive lung disease. She had the effects on her hands. And in that scenario, even a bacterial pneumonia, like a pneumococcal or haemophilus influenza pneumonia could be fatal as well.

So remember the theme here, Dr. Drew, is that in the setting of COVID, it was the frail and those who are particularly at risk for death of other pneumonias that indeed died of COVID.

So remember the theme here, Dr. Drew, is that in the setting of COVID, it was the frail and those who are particularly at risk for death of other pneumonias that indeed died of COVID.

Right, and the scleroderma patients get pulmonary hypertension, and God knows what that did to the, maybe she had diffused clotting or something. Who the hell knows? I mean, it's a whole thing. Well, okay, so no one ever said, at least not you or me, ever said COVID wasn't a severe illness.

Right, and the scleroderma patients get pulmonary hypertension, and God knows what that did to the, maybe she had diffused clotting or something. Who the hell knows? I mean, it's a whole thing. Well, okay, so no one ever said, at least not you or me, ever said COVID wasn't a severe illness.

We wondered how severe for people who were young, which generally without risk factors, it tends to be quite mild and still is, even though, and particularly as we've gone through the incarnations of the new variants. I personally am gravely concerned about the continued sort of man, the various variants.

We wondered how severe for people who were young, which generally without risk factors, it tends to be quite mild and still is, even though, and particularly as we've gone through the incarnations of the new variants. I personally am gravely concerned about the continued sort of man, the various variants.

sporadic mandates that are out there for young people to get them to go to school and to go to college and whatnot. And when there is only risk, even though yes, this is a severe illness and it hits an elderly patient with scleroderma and can kill them, it doesn't mean a 22 year old is at risk of that.

sporadic mandates that are out there for young people to get them to go to school and to go to college and whatnot. And when there is only risk, even though yes, this is a severe illness and it hits an elderly patient with scleroderma and can kill them, it doesn't mean a 22 year old is at risk of that.

And giving them a product that we know in that age group in particular causes myocarditis, pericarditis. I don't understand why we're still pushing that. And it sort of also brings up the other point. I'll let you talk at length about both these issues. Why we still demand we use the vaccines that produce the spike protein. Why we aren't using whole viral alternatives.

And giving them a product that we know in that age group in particular causes myocarditis, pericarditis. I don't understand why we're still pushing that. And it sort of also brings up the other point. I'll let you talk at length about both these issues. Why we still demand we use the vaccines that produce the spike protein. Why we aren't using whole viral alternatives.

Or going after nuclear capsid or something else other than the pathogenic protein.

Or going after nuclear capsid or something else other than the pathogenic protein.

You know, so many good points. One theme that applies to both the illness and the vaccine is what's called risk stratification, right? Not everybody is at equal risk. And, you know, those principles were never applied by our public health agencies and even not by schools or other institutions. Risk stratification is very important for the illness.

You know, so many good points. One theme that applies to both the illness and the vaccine is what's called risk stratification, right? Not everybody is at equal risk. And, you know, those principles were never applied by our public health agencies and even not by schools or other institutions. Risk stratification is very important for the illness.

I do think Dr. Jay Bhattacharya and the authors of the Great Barrington Declaration were right, that we really needed to take special protections for the seniors, And so those of us who had loved ones in congregate living facilities, nursing homes, and other types of institutions, that's where the mortality was. About 40% of the deaths came from nursing homes.

I do think Dr. Jay Bhattacharya and the authors of the Great Barrington Declaration were right, that we really needed to take special protections for the seniors, And so those of us who had loved ones in congregate living facilities, nursing homes, and other types of institutions, that's where the mortality was. About 40% of the deaths came from nursing homes.